| UniProt ID | PHAX_HUMAN | |
|---|---|---|
| UniProt AC | Q9H814 | |
| Protein Name | Phosphorylated adapter RNA export protein | |
| Gene Name | PHAX | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 394 | |
| Subcellular Localization | Nucleus, nucleoplasm . Nucleus, Cajal body . Cytoplasm . Located in the nucleoplasm and Cajal bodies. Shuttles between the nucleus and the cytoplasm. Shuttles between the nucleoplasm and Cajal bodies. | |
| Protein Description | A phosphoprotein adapter involved in the XPO1-mediated U snRNA export from the nucleus. Bridge components required for U snRNA export, the cap binding complex (CBC)-bound snRNA on the one hand and the GTPase Ran in its active GTP-bound form together with the export receptor XPO1 on the other. Its phosphorylation in the nucleus is required for U snRNA export complex assembly and export, while its dephosphorylation in the cytoplasm causes export complex disassembly. It is recycled back to the nucleus via the importin alpha/beta heterodimeric import receptor. The directionality of nuclear export is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. Its compartmentalized phosphorylation cycle may also contribute to the directionality of export. Binds strongly to m7G-capped U1 and U5 small nuclear RNAs (snRNAs) in a sequence-unspecific manner and phosphorylation-independent manner (By similarity). Plays also a role in the biogenesis of U3 small nucleolar RNA (snoRNA). Involved in the U3 snoRNA transport from nucleoplasm to Cajal bodies. Binds strongly to m7G-capped U3, U8 and U13 precursor snoRNAs and weakly to trimethylated (TMG)-capped U3, U8 and U13 snoRNAs. Binds also to telomerase RNA.. | |
| Protein Sequence | MALEVGDMEDGQLSDSDSDMTVAPSDRPLQLPKVLGGDSAMRAFQNTATACAPVSHYRAVESVDSSEESFSDSDDDSCLWKRKRQKCFNPPPKPEPFQFGQSSQKPPVAGGKKINNIWGAVLQEQNQDAVATELGILGMEGTIDRSRQSETYNYLLAKKLRKESQEHTKDLDKELDEYMHGGKKMGSKEEENGQGHLKRKRPVKDRLGNRPEMNYKGRYEITAEDSQEKVADEISFRLQEPKKDLIARVVRIIGNKKAIELLMETAEVEQNGGLFIMNGSRRRTPGGVFLNLLKNTPSISEEQIKDIFYIENQKEYENKKAARKRRTQVLGKKMKQAIKSLNFQEDDDTSRETFASDTNEALASLDESQEGHAEAKLEAEEAIEVDHSHDLDIF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MALEVGDME ------CCCEECCCC | 16.66 | 21406692 | |
| 14 | Phosphorylation | DMEDGQLSDSDSDMT CCCCCCCCCCCCCCC | 27.47 | 25159151 | |
| 16 | Phosphorylation | EDGQLSDSDSDMTVA CCCCCCCCCCCCCCC | 35.32 | 25159151 | |
| 18 | Phosphorylation | GQLSDSDSDMTVAPS CCCCCCCCCCCCCCC | 32.98 | 25159151 | |
| 21 | Phosphorylation | SDSDSDMTVAPSDRP CCCCCCCCCCCCCCC | 20.64 | 22617229 | |
| 25 | Phosphorylation | SDMTVAPSDRPLQLP CCCCCCCCCCCCCCC | 36.19 | 23663014 | |
| 39 | Phosphorylation | PKVLGGDSAMRAFQN CCCCCCHHHHHHHHH | 27.52 | 21815630 | |
| 47 | Phosphorylation | AMRAFQNTATACAPV HHHHHHHHHCCCCCC | 18.01 | 28555341 | |
| 55 | Phosphorylation | ATACAPVSHYRAVES HCCCCCCCHHEEEEC | 17.47 | 29978859 | |
| 57 | Phosphorylation | ACAPVSHYRAVESVD CCCCCCHHEEEECCC | 7.86 | 29978859 | |
| 62 | Phosphorylation | SHYRAVESVDSSEES CHHEEEECCCCCCCC | 25.32 | 27251275 | |
| 65 | Phosphorylation | RAVESVDSSEESFSD EEEECCCCCCCCCCC | 37.18 | 25137130 | |
| 66 | Phosphorylation | AVESVDSSEESFSDS EEECCCCCCCCCCCC | 40.70 | 25137130 | |
| 69 | Phosphorylation | SVDSSEESFSDSDDD CCCCCCCCCCCCCCC | 26.46 | 25137130 | |
| 71 | Phosphorylation | DSSEESFSDSDDDSC CCCCCCCCCCCCCCC | 45.55 | 25137130 | |
| 73 | Phosphorylation | SEESFSDSDDDSCLW CCCCCCCCCCCCCHH | 41.56 | 25137130 | |
| 77 | Phosphorylation | FSDSDDDSCLWKRKR CCCCCCCCCHHHHHH | 20.36 | 27251275 | |
| 102 | Phosphorylation | EPFQFGQSSQKPPVA CCCCCCCCCCCCCCC | 34.81 | 25159151 | |
| 103 | Phosphorylation | PFQFGQSSQKPPVAG CCCCCCCCCCCCCCC | 34.04 | 25627689 | |
| 105 | Acetylation | QFGQSSQKPPVAGGK CCCCCCCCCCCCCCC | 53.92 | 25953088 | |
| 112 | Acetylation | KPPVAGGKKINNIWG CCCCCCCCEECCHHH | 49.95 | 26051181 | |
| 146 | Phosphorylation | MEGTIDRSRQSETYN CCCCCCCHHHHHHHH | 30.81 | 21712546 | |
| 149 | Phosphorylation | TIDRSRQSETYNYLL CCCCHHHHHHHHHHH | 30.69 | 28796482 | |
| 151 | Phosphorylation | DRSRQSETYNYLLAK CCHHHHHHHHHHHHH | 23.47 | 28796482 | |
| 152 | Phosphorylation | RSRQSETYNYLLAKK CHHHHHHHHHHHHHH | 9.58 | 28796482 | |
| 154 | Phosphorylation | RQSETYNYLLAKKLR HHHHHHHHHHHHHHH | 7.84 | 28796482 | |
| 164 | Phosphorylation | AKKLRKESQEHTKDL HHHHHHHHHHHHHHH | 43.85 | 30108239 | |
| 168 | Phosphorylation | RKESQEHTKDLDKEL HHHHHHHHHHHHHHH | 26.04 | 30108239 | |
| 169 | "N6,N6-dimethyllysine" | KESQEHTKDLDKELD HHHHHHHHHHHHHHH | 59.19 | - | |
| 169 | Methylation | KESQEHTKDLDKELD HHHHHHHHHHHHHHH | 59.19 | - | |
| 178 | Phosphorylation | LDKELDEYMHGGKKM HHHHHHHHHCCCCCC | 8.28 | 29978859 | |
| 183 | Acetylation | DEYMHGGKKMGSKEE HHHHCCCCCCCCCCC | 44.15 | 25953088 | |
| 184 | Acetylation | EYMHGGKKMGSKEEE HHHCCCCCCCCCCCC | 52.33 | 30583977 | |
| 187 | Phosphorylation | HGGKKMGSKEEENGQ CCCCCCCCCCCCCCC | 33.14 | 29214152 | |
| 216 | Ubiquitination | NRPEMNYKGRYEITA CCCCCCCCCCEEEEC | 31.72 | 24816145 | |
| 222 | Phosphorylation | YKGRYEITAEDSQEK CCCCEEEECCCHHHH | 16.44 | 27251275 | |
| 226 | Phosphorylation | YEITAEDSQEKVADE EEEECCCHHHHHHHH | 31.57 | 17525332 | |
| 242 | Ubiquitination | SFRLQEPKKDLIARV HHHCCCCCHHHHHHH | 59.16 | 24816145 | |
| 284 | Phosphorylation | MNGSRRRTPGGVFLN ECCCCCCCCCCHHHH | 25.19 | 28555341 | |
| 296 | Phosphorylation | FLNLLKNTPSISEEQ HHHHHHCCCCCCHHH | 19.47 | 25159151 | |
| 316 | Phosphorylation | YIENQKEYENKKAAR EECCHHHHCCHHHHH | 31.66 | 27251275 | |
| 327 | Phosphorylation | KAARKRRTQVLGKKM HHHHHHHHHHHHHHH | 27.36 | - | |
| 332 | Acetylation | RRTQVLGKKMKQAIK HHHHHHHHHHHHHHH | 45.60 | 25953088 | |
| 339 | Ubiquitination | KKMKQAIKSLNFQED HHHHHHHHHCCCCCC | 52.48 | 29967540 | |
| 340 | Phosphorylation | KMKQAIKSLNFQEDD HHHHHHHHCCCCCCC | 23.56 | 28450419 | |
| 349 | Phosphorylation | NFQEDDDTSRETFAS CCCCCCCCCCHHHHH | 36.36 | 23927012 | |
| 350 | Phosphorylation | FQEDDDTSRETFASD CCCCCCCCCHHHHHH | 34.80 | 25159151 | |
| 353 | Phosphorylation | DDDTSRETFASDTNE CCCCCCHHHHHHHHH | 24.32 | 30266825 | |
| 356 | Phosphorylation | TSRETFASDTNEALA CCCHHHHHHHHHHHH | 40.55 | 30266825 | |
| 358 | Phosphorylation | RETFASDTNEALASL CHHHHHHHHHHHHCC | 32.25 | 30266825 | |
| 364 | Phosphorylation | DTNEALASLDESQEG HHHHHHHCCCHHHCC | 36.88 | 30266825 | |
| 368 | Phosphorylation | ALASLDESQEGHAEA HHHCCCHHHCCCHHH | 32.95 | 30266825 | |
| 388 | Phosphorylation | EAIEVDHSHDLDIF- HHHCCCCCCCCCCC- | 17.77 | 30266825 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PHAX_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PHAX_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PHAX_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CALD1_HUMAN | CALD1 | physical | 22863883 | |
| ENPL_HUMAN | HSP90B1 | physical | 22863883 | |
| IMA5_HUMAN | KPNA1 | physical | 26496610 | |
| NCBP1_HUMAN | NCBP1 | physical | 26496610 | |
| RL10_HUMAN | RPL10 | physical | 26496610 | |
| SSRP1_HUMAN | SSRP1 | physical | 26496610 | |
| TNR1A_HUMAN | TNFRSF1A | physical | 26496610 | |
| XYLK_HUMAN | FAM20B | physical | 26496610 | |
| SPAS2_HUMAN | SPATS2 | physical | 26496610 | |
| REEP4_HUMAN | REEP4 | physical | 26496610 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356, AND MASSSPECTROMETRY. | |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226, AND MASSSPECTROMETRY. | |